TNDM
TNDM
NASDAQ · Health Care

Tandem Diabetes Care Inc

$19.50
+0.49 (+2.58%)
As of Aug 8, 1:41 AM ET ·
Financial Highlights (FY 2026)
Revenue
995.87M
Net Income
-200,901,607
Gross Margin
53.8%
Profit Margin
-20.2%
Rev Growth
+8.2%
D/E Ratio
2.03
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 53.8% 53.8% 47.0% 47.0%
Operating Margin -18.4% -16.6% 15.5% 13.6%
Profit Margin -20.2% -19.2% 9.5% 12.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 995.87M 920.48M 506.05M 514.02M
Gross Profit 535.88M 495.31M 238.02M 241.76M
Operating Income -183,738,162 -152,846,238 78.47M 70.10M
Net Income -200,901,607 -167,123,991 48.01M 63.53M
Gross Margin 53.8% 53.8% 47.0% 47.0%
Operating Margin -18.4% -16.6% 15.5% 13.6%
Profit Margin -20.2% -19.2% 9.5% 12.4%
Rev Growth +8.2% +8.2% -3.6% +0.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 431.32M 431.32M 100.92M 108.12M
Total Equity 212.51M 212.51M 530.92M 572.70M
D/E Ratio 2.03 2.03 0.19 0.19
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -166,438,503 -146,147,128 116.78M 104.62M
Free Cash Flow 47.29M 46.73M